The companies will combine their extensive expertise and data sets to enhance Citeline Study Feasibility and help clinical trial teams accelerate the time to first and last patient in NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) — Informa Pharma Intelligence,
WM’s Global Expansion via its VSMP Affiliates is already one of the fastest in history – providing a free expansion capacity worldwide for WM, free additional revenues for entities acquiring VSMPs and cost reductions of up to 80% for Members
Collaboration to scale green hydrogen throughout industrial and mobility sectors, while advancing development of key hydrogen infrastructure and fueling capabilities HOUSTON and LATHAM, N.Y, Oct. 13, 2021 (GLOBE NEWSWIRE) — Phillips 66 (NYSE: PSX) and Plug Power Inc. (NASDAQ: PLUG),
The Seventh Generation of Zonin Celebrates the First 200 Years of the Company’s History 200th Anniversary Celebration: 1821-2021 GAMBELLARA, Italy, Oct. 13, 2021 (GLOBE NEWSWIRE) — 1821 – 2021: Zonin1821 celebrates 200 years of history and seven generations that have
Appoints global leader to action strategy and commits to science-based targets and Net Zero by 2030 TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) — Colliers, a leading diversified professional services and investment management company (NASDAQ, TSX: CIGI), today released Elevate the
MUNICH, Germany, Oct. 13, 2021 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX: DSG), the global leader in uniting logistics-intensive businesses in commerce, announces that the German fashion retailer SportSpar.de has increased its ability to ship customer orders by
Sportradar underlines its commitment to protecting the integrity of sport with the official launch of Universal Fraud Detection System free of charge NEW YORK and ST. GALLEN, Switzerland, Oct. 13, 2021 (GLOBE NEWSWIRE) — Sportradar Integrity Services, a global supplier
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix -Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and Europe for the treatment of uterine fibroids- –Financing agreement with JGB Management to fund the planned launch of
The companies will combine their extensive expertise and data sets to enhance Citeline Study Feasibility and help clinical trial teams accelerate the time to first and last patient in NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) — Informa Pharma Intelligence,
WM’s Global Expansion via its VSMP Affiliates is already one of the fastest in history – providing a free expansion capacity worldwide for WM, free additional revenues for entities acquiring VSMPs and cost reductions of up to 80% for Members
Collaboration to scale green hydrogen throughout industrial and mobility sectors, while advancing development of key hydrogen infrastructure and fueling capabilities HOUSTON and LATHAM, N.Y, Oct. 13, 2021 (GLOBE NEWSWIRE) — Phillips 66 (NYSE: PSX) and Plug Power Inc. (NASDAQ: PLUG),
The Seventh Generation of Zonin Celebrates the First 200 Years of the Company’s History 200th Anniversary Celebration: 1821-2021 GAMBELLARA, Italy, Oct. 13, 2021 (GLOBE NEWSWIRE) — 1821 – 2021: Zonin1821 celebrates 200 years of history and seven generations that have
Appoints global leader to action strategy and commits to science-based targets and Net Zero by 2030 TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) — Colliers, a leading diversified professional services and investment management company (NASDAQ, TSX: CIGI), today released Elevate the
MUNICH, Germany, Oct. 13, 2021 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX: DSG), the global leader in uniting logistics-intensive businesses in commerce, announces that the German fashion retailer SportSpar.de has increased its ability to ship customer orders by
Sportradar underlines its commitment to protecting the integrity of sport with the official launch of Universal Fraud Detection System free of charge NEW YORK and ST. GALLEN, Switzerland, Oct. 13, 2021 (GLOBE NEWSWIRE) — Sportradar Integrity Services, a global supplier
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix -Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and Europe for the treatment of uterine fibroids- –Financing agreement with JGB Management to fund the planned launch of
